PPA proud to support Kyowa Kirin in their work to fight XLH

On Rare Disease Day 2022, the voice of the XLH community in Australia was heard, with the extent of the physical, emotional and social burden of X linked hypophosphataemia revealed for the first time. XLH is a lifelong condition that impacts the whole body.

PPA was proud to support Kyowa Kirin in their work with partner XLH Australia (XLHA) to conduct important research which provided valuable insights into what it is really like to live with the rare, genetic disease – from painful bone deformities and leg-breaking surgeries to clinical depression and self-harm, alongside feelings of isolation and frustration about the severe lack of disease awareness. For full survey results, visit https://lnkd.in/gm-fVYdF

Healthcare and compassion are things we all deserve. XLHA are hoping for better access to compassionate healthcare and have fingers crossed for a brighter future.

Visit website to learn more about XLH: www.xlhaustralia.com

Congratulations to Naomi Ford and Sandy Bevc for their tireless and unwavering advocacy efforts on behalf of the XLHA community and sincere thanks to the Hon Greg Hunt MP, the Hon Mark Butler MP, Mr Trent Zimmerman MP and Dr Mike Freelander MP, for their bipartisan support of rare disease day, as well as John Alexander MP for his ongoing support through #PFOM.

Related Posts

PPA takes part in the RememBEARance Campaign

Today Precision Public Affairs takes part in the RememBEARance campaign.

Launch of the Medicines Waiting Room

PPA was honoured to support Tori Brown and Eli Lilly in their official launch of the ‘Medicines Waiting Room Report’ last week at Australian Parliament House.

PPA Supports the Establishment of the ETAA

Precision Public Affairs is proud to have supported the establishment of the Emerging Therapeutics Association of Australia which aims to bring together all aspects of emerging therapies, from licensed cultivation, manufacturing, distribution and research, to advance Australian Government legislation to meet the needs of Australian #patients and prescribers by making legal access the preferred patient choice.